1. Home
  2. RPGL vs DRMA Comparison

RPGL vs DRMA Comparison

Compare RPGL & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RPGL

Republic Power Group Limited Class A Ordinary Shares

N/A

Current Price

$0.50

Market Cap

3.6M

Sector

Technology

ML Signal

N/A

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

HOLD

Current Price

$1.18

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPGL
DRMA
Founded
2015
2014
Country
Singapore
United States
Employees
8
8
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RPGL
DRMA
Price
$0.50
$1.18
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
1.1M
1.7M
Earning Date
05-16-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.59
52 Week High
$8.44
$7.33

Technical Indicators

Market Signals
Indicator
RPGL
DRMA
Relative Strength Index (RSI) 42.48 41.25
Support Level $0.30 $1.14
Resistance Level $0.60 $1.84
Average True Range (ATR) 0.14 0.15
MACD -0.08 0.03
Stochastic Oscillator 2.20 2.19

Price Performance

Historical Comparison
RPGL
DRMA

About RPGL Republic Power Group Limited Class A Ordinary Shares

Republic Power Group Ltd is a provider of customized ERP software solutions, consulting and technical support services, and peripheral hardware to corporate clients and government agencies, including airports, cruise terminals, and technology, trading, and logistics companies. The Company operates from Singapore and has historically served clients in Singapore and Malaysia, offering ERP systems with functions such as accounting, procurement, workflow automation, real-time monitoring, and capabilities including planning, surveillance, and threat detection. The Company leverages artificial intelligence and modular algorithms to address complex operational requirements and integrates sensors, controls, and other hardware to enable IoT connectivity with autonomous or semiautonomous outcomes.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology for patients suffering with acne. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin.

Share on Social Networks: